At the end of the latest market close, Meridian Bioscience Inc. (VIVO) was valued at $19.85. In that particular session, Stock kicked-off at the price of $19.70 while reaching the peak value of $20.14 and lowest value recorded on the day was $19.05. The stock current value is $19.67.Recently in News on November 24, 2021, Meridian Bioscience Announces Retirement of Chairman David Phillips. Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today that David Phillips, Chairman of the Board of Directors, will retire from the Board of Directors and not seek re-election when his term ends in January 2022. The Board of Directors will elect a new chair when Mr. Phillips’ term expires and will not replace the vacated seat, which will reduce the number of directors to eight. You can read further details here
Meridian Bioscience Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $30.65 on 02/12/21, with the lowest value was $17.00 for the same time period, recorded on 06/02/21.
Meridian Bioscience Inc. (VIVO) full year performance was 13.57%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Meridian Bioscience Inc. shares are logging -35.82% during the 52-week period from high price, and 17.78% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $16.70 and $30.65.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 858137 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Meridian Bioscience Inc. (VIVO) recorded performance in the market was 5.24%, having the revenues showcasing 1.65% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 798.80M, as it employees total of 560 workers.
Specialists analysis on Meridian Bioscience Inc. (VIVO)
During the last month, 0 analysts gave the Meridian Bioscience Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 19.51, with a change in the price was noted -2.46. In a similar fashion, Meridian Bioscience Inc. posted a movement of -11.12% for the period of last 100 days, recording 385,464 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for VIVO is recording 0.16 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.16.
Trends and Technical analysis: Meridian Bioscience Inc. (VIVO)
Raw Stochastic average of Meridian Bioscience Inc. in the period of last 50 days is set at 50.38%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 46.70%. In the last 20 days, the company’s Stochastic %K was 64.19% and its Stochastic %D was recorded 79.03%.
Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 5.24%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -6.20%, alongside a boost of 13.57% for the period of the last 12 months. The shares increased approximately by -2.09% in the 7-day charts and went down by 6.15% in the period of the last 30 days. Common stock shares were driven by 1.65% during last recorded quarter.